Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-065664
Filing Date
2012-12-18
Accepted
2012-12-18 17:32:45
Documents
1
Period of Report
2012-09-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rrd363838.html 4  
1 PRIMARY DOCUMENT rrd363838.xml 4 3661
  Complete submission text file 0001181431-12-065664.txt   5340
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Issuer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7840 VIRGINIA OAK DRIVE GAINSVILLE VA 20155
Business Address
COWELL RICHARD (Reporting) CIK: 0001254951 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35560 | Film No.: 121272380